Mirae Asset Global Etfs Holdings Ltd. Royalty Pharma PLC Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 79,990 shares of RPRX stock, worth $2.63 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
79,990
Previous 66,501
20.28%
Holding current value
$2.63 Million
Previous $1.7 Million
46.82%
% of portfolio
0.01%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding RPRX
# of Institutions
484Shares Held
283MCall Options Held
2.51MPut Options Held
941K-
Morgan Stanley New York, NY41MShares$1.35 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.7MShares$1.21 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$757 Million0.01% of portfolio
-
Baillie Gifford & CO13.4MShares$441 Million0.38% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$400 Million0.39% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.4B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...